Aurora Kinase Overview
| Cat No. | Product Name | CAS No. | Purity | Order |
|---|---|---|---|---|
| I021771 | Alisertib sodium anhydrous | 1028486-06-7 | 98.0% | Inquiry |
| I031229 | LY3295668 | 1919888-06-4 | 98.0% | Inquiry |
| I027660 | FMF-03-145-1 | 2133001-88-2 | 98.0% | Inquiry |
| I024273 | CD532 | 1639009-81-6 | 98.0% | Inquiry |
| I021676 | AKI603 | 1432515-73-5 | 98.0% | Inquiry |
| I020557 | Aurora B inhibitor 1 | 937276-52-3 | ≥ 95% | Inquiry |
| I019629 | Aurora inhibitor 1 | 2227019-45-4 | ≥ 95% | Inquiry |
| I018696 | AAPK-25 | 2247919-28-2 | ≥ 95% | Inquiry |
| I018278 | Ilorasertib hydrochloride | 1847485-91-9 | ≥ 95% | Inquiry |
| I002451 | Tripolin A | 1148118-92-6 | ≥ 95% | Inquiry |
| R067031 | Aurora Kinase Inhibitor III | 879127-16-9 | ≥ 95% | Inquiry |
| R065595 | Aurora Kinase Inhibitor II | 331770-21-9 | ≥ 95% | Inquiry |
| R049577 | Phthalazinone pyrazole | 880487-62-7 | ≥ 95% | Inquiry |
| R010825 | Retreversine | 1028332-91-3 | ≥ 95% | Inquiry |
| I010888 | TC-A 2317 hydrochloride | 1245907-03-2 | ≥ 95% | Inquiry |
| I009714 | TAS-119 | ≥ 95% | Inquiry | |
| I009543 | SNS-314 | 1057249-41-8 (free base) | ≥ 95% | Inquiry |
| I006675 | ENMD-2076 | 934353-76-1 | ≥ 95% | Inquiry |
| I005931 | Cenisertib (AS703569) | 871357-89-0 | ≥ 95% | Inquiry |
| R053853 | Derrone | 76166-59-1 | ≥ 95% | Inquiry |
| I005549 | TAK-901 | 934541-31-8 | ≥ 95% | Inquiry |
| I005603 | PF-03814735 | 942487-16-3 | ≥ 95% | Inquiry |
| I005606 | GSK-1070916 | 942918-07-2 | ≥ 95% | Inquiry |
| I005607 | CCT-129202 | 942947-93-5 | ≥ 95% | Inquiry |
| I005627 | AMG-900 | 945595-80-2 | ≥ 95% | Inquiry |